All News

A new direct-to-consumer test analyzes saliva for 3 BRCA variants that may elevate the risk of various types of cancer.

Mylan will reduce the wholesale acquisition costs of Smyfi Lo and Cimduo, which are both combination therapies for HIV.

Targeting an energy-related molecule could prevent the onset of autoimmune diseases.

A new direct-to-consumer test analyzes saliva for 3 BRCA variants that may elevate the risk of various types of cancer.

The IDSA and SHEA have made a recent update to the previously published practice guidelines for CDI. While many of the recommendations remain the same, there are a few key changes that the update has addressed.

HIV packages a key viral protein in exosomes to transport throughout the body.

An enzyme blockade could assist remyelination in patients with peripheral nerve damage.

Stem cell treatments improved muscle strength and disability among patients with multiple sclerosis.

Personalized inpatient assessments prior to prescribing asthma therapy to pediatric patients can improve the accuracy and quality of care.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Newly-proposed legislation would block the expansion of association health plans.

New study findings suggest that more at-risk individuals should take pre-exposure prophylaxis to prevent HIV.

Are you a busy professional? Think eating healthy is difficult? It doesn't have to be!

Opioid allergies are often misdiagnosed. Improper allergy diagnosis may lead to delays in treatment and unnecessary drug avoidance.

In an effort to evaluate whether switching from a reference biologic to a biosimilar could lead to altered clinical outcome, a research team, led by Hillel Cohen, PhD, conducted a systematic literature review of all available switching studies.

Patients with cell phones at the pharmacy is a growing issue.

An international team of respiratory disease specialists looked back at 2017 and assembled a review of the current approaches to asthma and chronic obstructive pulmonary disease.

Daclizumab (Zinbryta) may cause brain inflammation among patients with relapsing multiple sclerosis.

Technology is great when it works, but in this case, the issue of recieving the wrong amount of insulin can be problematic.

Biologic drug demonstrates efficacy in moderate-to-severe asthma.

Patients with colon cancer who regularly consumed tree nuts had a 46% improvement in disease-free survival.

Sanofi recently announced that the FDA has accepted the supplemental Biologics License Application (sBLA) of dupilumab (Dupixent) for the maintenance treatment of asthma.

The FDA advises patients to be cautious when purchasing influenza drugs online.

Current treatments for neurofibromatosis tumors may result in drug resistance.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

The authors of the study acknowledged that there is much more to be understood about the factors that affect adolescents and young adults at high risk for contracting or transmitting HIV.

In comparing environmental intervention costs with those of health care utilization, costs are reduced further with environmental intervention.

Pharmacy conferences provide great opportunities to expand your professional horizons.